1Ostergard T;Hansen TK;Nyholm B.Circulating ghrelin concentrations are reduced in healthy offspring of type 2 diabetic subjects,and are increased in women independent of a family history of type 2 diabetes,2003(01).
2Ikezaki A;Hosoda H;Ito K.Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1,but not with leptin in obese children and adolescents,2002(12).
3Sun Y;Butte NF;Garcia JM.Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance,2008.
4Akamizu T;Takaya K;Irako T.Pharmacokinetics,safety and endocrine and appetite effects of ghrelin administration in young health subjects[J],2004(04).
5Hayashida T;Nakahara K;Mondal MS.Ghrelin in neonatal rats:distribution in stomach and its possible role,2002.
6Mclaughlin T;Abbasi F;Lamendola C.Plasma ghrelin concentration are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls,2004(04).
7Toshinai K;Mondal MS;Nakazato M.Upregulation of Ghrelin expression in the stomach upon fasting,insulin-induced hypoglycemia,and leptin administration[J],2001.
8Zhang JV;Ren PG;Avsian-Kretchmer O.Obestatin,a peptide encoded by the ghrelin gene,opposes ghrelin's effects on food intake[J],2005(5750).
9Ng PC;Lee CH;Lam CW.Plasma ghrelin and resistin concentration are suppressed in infants of insulin-dependent diabetic mothers,2004(11).
10Kos K;Syn WK;Lewandowski KC.Comparison of maternal ghrelin and leptin in healthy mothers and mothers with Type 1 diabetes,2008(12).
二级参考文献10
1曹泽毅．中华妇产科学[M]．北京：人民卫生出版社，2005：2814．
2Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormonereleasing acylated peptide from stomach [J]. Nature. 1999, 402(6762): 656.
3Dong J, Peeters TL, Desmet B, et al. Role of endogenous ghrelin in the hyperphagia of mice with streptozotocin-induced diabetes [J].Endocrinology, 2006,147(6):2634.
4Masaoka T, Suzuki H, Hosoda H, et al. Enhanced plasma ghrelin levels in rats with streptozotocin-induced diabetes [J]. FERS Lett,2003,541(1/3):64.
5Broglio F, Prodam F, Riganti F, et al. Ghrelin: from somatotrope secretion to new perspectives in the regulation of peripheral metabolic functions [J]. Front Horm Res, 2006,35:102.
6Vartiainen J, Kesaniemi YA, Ukkola O, et al. Sequence varians fasting plasma total ghrelin concentrations, and body mass index [J].Metabolism, 2006,55(10):1420.
7Poykko SM, Kellokoshi E, Horkko S, et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes [J]. Diabetes, 2003, 52(10):2546.
8Takahashi H, Kurose Y, Kobayashi S, et al. Ghrelin enhances glucose-induced insulin secretion in scheduled meal-fed sheep [J]. J Endocrinol, 2006, 189.(1):67
9Egido EM, Rodriguez-Gallardo J, Silvestre RA, et al. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion [J]. J Endocrinol, 2002,146(2):241.
10Ostergard T, Hansen TK, Nyholm B, et al. Circulating ghrelin concentrations are reduced in healthy offspring of type 2 diabetic subjects, and are increased in women independent of a family history of type 2 diabetes [J]. Diabetologia, 2003, 46(1):134.
2YAMASHITA H, SHAO J, FRIEDMAN J E. Physiologic and mo- lecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes mellitus [ J ]. Clin Obstet Gynecol, 2000, 43(1) :87 -98.
3DONG J, PEETERS T L, DESMET B, et al. Role of endogenous ghrelin in the hyperphagia of mice with streptozotoein - induced diabetes [ J ]. Endocrinology,2006,147 (6) :2634.
4DEZAKI K, SONE H, YADA T. Ghrelin is a physiological regulator of insulin release in pancreatic islets and g1ucose homeostasis [ J ]. Pharmacol Tber,2008,118 ( 2 ) :239 - 249.
5TOSHINAI K, MONDAL M S, NAKAZATO M, et al. Upregulation of Ghrehn expression in the stomach upon fasting, insulin - in- duced hypoglycemia, and leptin administration [ J]. Biochem Bio- phys Res Commun,2001,281 : 1220 - 1225.
6VARTIAINEN J, KESANIEMI Y A, UKKOLA O, et al. Sequence variants fasting plasma total ghrelin concentrations, and body mass index[ J ]. Metabolism ,2G96,55 (10) : 1420.
7POYKKO S,UKKOLA O,KAUMA H,et al. Ghrelin Arg51Gln mu- tation is a risk factor for type 2 diabetes and hypertension in a ran- dom sample of middle - aged subjects [ J ]. Diabetologia, 2003,46 (4) :455 -458.
8KATSUKI A, URAKAWA H, GABAZZA E C, et al. Circulating levels of active ghrelin is associated with abdominal adiposity, hy- perinsulinemia and insulin resistance in patients with type 2 diabe- tes mellitus[ J]. Endocrinology,2004,151:2546 - 2553.
9OSTERGARD T, HANSEN TK, NYHOLM B, et al. Circulating gh- relin concentrations are reduced in healthy offspring of type 2 dia- betic subjects, and are increased in women independent of a family history of type 2 diabetes [J]. Diabetologia, 2003,46 ( 1 ) : 134.
10GUALILLO O, CAMINOS J, BLANCO M, et al. Ghrelin, a novel placental - derived hormone[J]. Endocrinology, 2001,142 : 788 - 794.
